SCHEMBL1604481

SCHEMBL1604481

CCC=CCC=CCC=CCC=CCC=CCCCC(=O)NCCSSCCNC(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 7/20 0.66
▸ EPHX2 P34913 2/20 0.55
▸ KMT2A Q03164 3/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ SLC6A5 Q9Y345 1/20 0.54
▸ ALDH1A1 P00352 4/20 0.54
▸ FAAH O00519 2/20 0.53
▸ CNR2 P34972 2/20 0.53
▸ TRPM8 Q7Z2W7 1/20 0.53
▸ KCNK3 O14649 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ TRPV1 Q8NER1 1/20 0.53
▸ F7 P08709 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.53
▸ CYP19A1 P11511 1/20 0.53
▸ F3 P13726 1/20 0.53
▸ RXRA P19793 1/20 0.53
▸ PTGS1 P23219 1/20 0.53
▸ PPARG P37231 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14739704 1.00 CNR1 (0.66) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL12478623 0.94 CNR1 (0.73) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL14739941 0.92 CNR1 (0.64) CNR1EPHX2KMT2AMAPTALDH1A1
SCHEMBL14739939 0.92 CNR1 (0.64) CNR1EPHX2KMT2AMAPTALDH1A1
SCHEMBL12685101 0.92 CNR1 (0.69) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL14740184 0.91 CNR1 (0.64) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL14740182 0.91 CNR1 (0.64) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL14739323 0.91 CNR1 (0.64) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL14739321 0.91 CNR1 (0.64) CNR1EPHX2KMT2AMEN1MAPT
SCHEMBL14752451 0.90 CNR1 (0.68) CNR1EPHX2KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170073305-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE CATABASIS PHARMACEUTICALS, INC. 2017-03-16 — — US disclosed
US-20130059801-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE CATABASIS PHARMACEUTICALS, INC. (US) 2013-03-07 — — US disclosed
US-20110082202-A1 FATTY ACID ACIFRAN DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059801-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE FASN, FADS1, ELOVL5 CNR1 1072/4885EPHX2 788/4885KMT2A 1112/4885
US-20110082202-A1 FATTY ACID ACIFRAN DERIVATIVES AND THEIR USES FABP4, FASN, ELOVL6 CNR1 1599/4885EPHX2 2683/4885KMT2A 3353/4885
US-20170073305-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE FASN, FADS1, ELOVL5 CNR1 1072/4885EPHX2 788/4885KMT2A 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback